Literature DB >> 9187136

Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis.

X Lin1, I H Gelman.   

Abstract

SSeCKS (pronounced essex) encodes a major protein kinase C substrate, the expression of which is down-regulated in src- and ras-transformed rodent fibroblasts but not in raf-transformed rodent fibroblasts (X. Lin et al., Mol. Cell. Biol., 15: 2754-2762, 1995). Using a panel of ras-transformed or revertant Rat-6 cells that exhibit selective parameters of transformation, we show that down-regulation of SSeCKS correlates with anchorage-independent growth. Cotransfection of NIH3T3 fibroblasts with an SSeCKS expression plasmid decreased 6-30-fold the ability of a v-src expressor plasmid to induce colonies in soft agar. To differentiate between possible tumor suppressive or growth-inhibitory effects of SSeCKS, we developed conditionally transformed cell lines (expressing ts72v-src) with tetracycline-regulated SSeCKS expression. SSeCKS suppressed the ability of v-src to induce increased cellular refractility, focus formation, soft agar colony formation, in vitro invasiveness in Matrigel, and growth in low serum (0.5%) but did not inhibit cell proliferation in high serum (10%) at the permissive (35 degrees C) temperature for src kinase activity. However, at the nonpermissive (39.5 degrees C) temperature, SSeCKS induced growth arrest. SSeCKS expression did not affect: (a) the protein level, in vivo or in vitro kinase activity of ts72src; (b) the activity of jun NH2-terminal kinase; and (c) the level of mitogen-activated protein kinase (extracellular signal-regulated kinase 2) protein. However, extracellular signal-regulated kinase 2 activity was induced 5-10-fold by SSeCKS in the presence of active src. SSeCKS reversed the ability of v-src to decrease the formation of vinculin-associated adhesion plaques, actin-based stress fibers, and filopodia structures. These data suggest a tumor suppressive role for SSeCKS via the control of cytoskeletal architecture and cell signaling.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9187136

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

1.  SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G(1)-->S progression by controlling the expression and cellular compartmentalization of cyclin D.

Authors:  X Lin; P Nelson; I H Gelman
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

Review 2.  A-kinase anchoring proteins as potential drug targets.

Authors:  Jessica Tröger; Marie C Moutty; Philipp Skroblin; Enno Klussmann
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 3.  Suppression of tumor and metastasis progression through the scaffolding functions of SSeCKS/Gravin/AKAP12.

Authors:  Irwin H Gelman
Journal:  Cancer Metastasis Rev       Date:  2012-12       Impact factor: 9.264

4.  Gravin regulates mesodermal cell behavior changes required for axis elongation during zebrafish gastrulation.

Authors:  Douglas C Weiser; Ujwal J Pyati; David Kimelman
Journal:  Genes Dev       Date:  2007-06-15       Impact factor: 11.361

5.  Loss of the SSeCKS/Gravin/AKAP12 gene results in prostatic hyperplasia.

Authors:  Shin Akakura; Changhui Huang; Peter J Nelson; Barbara Foster; Irwin H Gelman
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

6.  A critical role of SRC-suppressed C kinase substrate in rat astrocytes after chronic constriction injury.

Authors:  Yinyin Xia; Haiou Liu; Aiguo Shen; Yonghua Liu; Linlin Sun; Tao Tao; Qing Ke; Chun Cheng
Journal:  Neuromolecular Med       Date:  2009-11-25       Impact factor: 3.843

7.  Elevated AKAP12 in paclitaxel-resistant serous ovarian cancer cells is prognostic and predictive of poor survival in patients.

Authors:  Nicholas W Bateman; Elizabeth Jaworski; Wei Ao; Guisong Wang; Tracy Litzi; Elizabeth Dubil; Charlotte Marcus; Kelly A Conrads; Pang-ning Teng; Brian L Hood; Neil T Phippen; Lisa A Vasicek; William P McGuire; Keren Paz; David Sidransky; Chad A Hamilton; G Larry Maxwell; Kathleen M Darcy; Thomas P Conrads
Journal:  J Proteome Res       Date:  2015-03-19       Impact factor: 4.466

8.  Carcinogen-induced squamous papillomas and oncogenic progression in the absence of the SSeCKS/AKAP12 metastasis suppressor correlate with FAK upregulation.

Authors:  Shin Akakura; Rene Bouchard; Wiam Bshara; Carl Morrison; Irwin H Gelman
Journal:  Int J Cancer       Date:  2011-04-01       Impact factor: 7.396

9.  SSeCKS/Gravin/AKAP12 inhibits cancer cell invasiveness and chemotaxis by suppressing a protein kinase C- Raf/MEK/ERK pathway.

Authors:  Bing Su; Yahao Bu; David Engelberg; Irwin H Gelman
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

10.  Gravin is a transitory effector of polo-like kinase 1 during cell division.

Authors:  David A Canton; C Dirk Keene; Katie Swinney; Lorene K Langeberg; Vivian Nguyen; Laurence Pelletier; Tony Pawson; Linda Wordeman; Nephi Stella; John D Scott
Journal:  Mol Cell       Date:  2012-10-11       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.